Sign inJoin waitlistJoin the waitlist

Anup Kasi

Associate Professor, Medical Oncology · University of Kansas School of Medicine

Credentials: · · · · ·

History

University of Kansas School of Medicine
Present

Hematology and Medical Oncology
University of Kansas School of Medicine

Research

Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study
The Lancet · 2020 · 1,345 citations
Randomized Phase III Trial of Pegvorhyaluronidase Alfa With Nab-Paclitaxel Plus Gemcitabine for Patients With Hyaluronan-High Metastatic Pancreatic Adenocarcinoma
Journal of Clinical Oncology · 2020 · 422 citations
Total Neoadjuvant Therapy vs Standard Therapy in Locally Advanced Rectal Cancer: A Systematic Review and Meta-analysis
Systematic review or meta-analysis · JAMA Network Open · 2020 · First of 7 authors · Corresponding · 327 citations

Weijing Sun
25 papers
Raed Al Rajabi
16 papers
Joaquina Baranda
15 papers
AS
Anwaar Saeed
14 papers
RP
Robin Park
11 papers · 11 as a resident
Ravi Paluri
10 papers
Stephen Williamson
9 papers
Jeremy Warner
7 papers
Anusha Chidharla
6 papers · 6 as a resident
Ashish Manne
6 papers · 3 as a fellow
Clara Hwang
6 papers
Elizabeth Wulff
6 papers

Clinical trials

Trial to Evaluate irAEs With Different Standard of Care Dosing Strategies of Standard of Care Immunotherapies
Principal investigator · Recruiting · Phase 3
University of Kansas Medical Center
2025–2029
Onvansertib in Combination With NALIRIFOX for First Line Treatment of Advanced Pancreatic Cancer
Principal investigator · Recruiting · Phase 1, Phase 2
University of Kansas Medical Center
2025–2027
Tg01 Vaccine / Qs-21 Stimulon™ With Or Without Balstilimab As Maintenance Therapy Following Adjuvant Chemotherapy In Patients With Resected Pancreatic Cancer
Principal investigator · Active not recruiting · Phase 2
University of Kansas Medical Center
2022–2025
CEND-1 in Combination with Neoadjuvant FOLFIRINOX with or Without Panitumumab
Principal investigator · Active not recruiting · Phase 1, Phase 2
Anup Kasi
2021–2026